From crawl to run: The reality of AI implementation in pharma with Arthur Alston (Coming soon)

Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with Arthur Alston, Head of Solid Tumours and Radioligand Therapy at Novartis Australia and New Zealand, who brings over 25 years of life sciences experience as both a trained physician and commercial leader. They explore Arthur's "Crawl, Walk, Run" framework for AI adoption, why most pharma companies are still crawling despite buying licenses and the brutal realities of moving from enthusiasm to actual implementation.

Arthur shares practical insights on building AI agents across multiple functions, the limitations of RAG architecture in pharma, navigating regulatory compliance in pharmacovigilance, and where executives are actually seeing ROI.

He also addresses the biggest mistakes companies make, why company policy might be your biggest barrier, and where AI can genuinely reduce administrative burden to help healthcare professionals focus on patient care.

Find all our episodes on YouTube, Buzzsprout and Spotify.